Nucleic acid approaches to antibody-based therapeutics for COVID-19: A perspective
J Allergy Clin Immunol
.
2020 Sep;146(3):537-540.
doi: 10.1016/j.jaci.2020.06.022.
Epub 2020 Jul 3.
Authors
Elizabeth Parzych
1
,
David B Weiner
2
Affiliations
1
Vaccine and Immunotherapy Center, The Wistar Institute, Philadelphia, Pa.
2
Vaccine and Immunotherapy Center, The Wistar Institute, Philadelphia, Pa. Electronic address: dweiner@wistar.org.
PMID:
32623068
PMCID:
PMC7332441
DOI:
10.1016/j.jaci.2020.06.022
No abstract available
Keywords:
COVID-19; SARS-CoV-2; gene delivery; monoclonal antibody; nucleic acid.
Publication types
Editorial
Comment
MeSH terms
Antibodies, Monoclonal
Betacoronavirus*
COVID-19
Coronavirus Infections*
Humans
Pandemics*
Pneumonia, Viral*
SARS-CoV-2
Substances
Antibodies, Monoclonal